Evidence map›Paper›PMID 37219076›Full record

ReviewJournal of investigative medicine high impact case reports

Recurrence of T-Cell Prolymphocytic Leukemia With a Rare Presentation as Diffuse Generalized Skin Lesion.

Mustafa Wasifuddin, Hafsa Sabzposh, Lishi Sun, Richard Wu, Jen C Wang

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mustafa WasifuddinDepartment of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.
Hafsa SabzposhDepartment of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.
Lishi SunDivision of Hematology and Oncology, Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.
Richard WuDivision of Pathology, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.
Jen C WangDivision of Hematology and Oncology, Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.ORCID 0000-0002-9623-6645
Brookdale University Hospital and Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive neoplasm that originates from mature post-thymic T-cells. Cutaneous manifestations are a common presentation in T-PLL but rarely are a presentation in the recurrent setting. Here, we describe the case of a 75-year-old female with a history of T-PLL-who at the time of initial diagnosis did not exhibit any rash-presenting with diffuse rash, facial swelling, sore throat, and dysphagia 7 months later and was found to have recurrent T-PLL. She had diffuse lymphadenopathy and diffuse skin lesions. Biopsy of the skin lesions also confirmed infiltration with T-PLL cells. After review of the literature, no previously reported cases of recurrent T-PLL presented as diffuse skin lesions. This case demonstrates that recurrent T-PLL may present with diffuse rash, respiratory distress, and anasarca. It is important to stay vigilant in patients with history of T-PLL to recognize signs of recurrent disease to allow prompt diagnosis and treatment.

Indexed as

ExanthemaLeukemia, Prolymphocytic, T-CellSkin DiseasesSkin NeoplasmsAgedFemaleHumansSkinalemtuzumabdermatologyerythemahematology oncologyPentostatinT-cell prolymphocytic leukemia (T-PLL)

Identifiers

PMID37219076
PMCPMC10214040
OpenAlexW4377564628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.